Cell therapy
Showing 9976 - 10000 of >10,000
Aggressive NK Cell Leukemia Trial in Hiroshima (PPMX-T003)
Recruiting
- Aggressive NK Cell Leukemia
-
Hiroshima, JapanHiroshima University Hospital
May 9, 2023
Glioma, Glioneuronal Tumor, Choroid Plexus Tumor Trial (Observational)
Not yet recruiting
- Glioma
- +12 more
- Observational
- (no location specified)
Feb 17, 2022
Tumor Infiltrating Lymphocytes, Safety, Advanced Solid Tumor Trial in Beijing (TIL therapy)
Recruiting
- Tumor Infiltrating Lymphocytes
- +5 more
- TIL therapy
-
Beijing, Beijing, ChinaChinese PLA General Hospital
Dec 19, 2022
Chronic Kidney Diseases Trial (Placebo, Vitamin K 2)
Not yet recruiting
- Chronic Kidney Diseases
- Placebo
- Vitamin K 2
- (no location specified)
Jul 4, 2023
Clear Cell Renal Cell Carcinoma Trial in Beijing (68Ga-NY104)
Completed
- Clear Cell Renal Cell Carcinoma
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital
Feb 6, 2023
Solid Tumors Trial run by the National Cancer Institute (NCI) (Bevacizumab, Dasatinib)
Completed
- Solid Tumors
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 19, 2023
Metastatic Lung Non-Small Cell Squamous Carcinoma, Metastatic Lung Non-Squamous Non-Small Cell Carcinoma, Stage IIIB Lung Cancer
Active, not recruiting
- Metastatic Lung Non-Small Cell Squamous Carcinoma
- +7 more
- Carboplatin
- +2 more
-
Los Angeles, California
- +9 more
Dec 17, 2022
Chronic Lymphocytic Leukemia- Binet Staging System Trial in Spain (Acalabrutinib 100 MG Oral Capsule)
Recruiting
- Chronic Lymphocytic Leukemia- Binet Staging System
- Acalabrutinib 100 MG Oral Capsule
-
A Coruña, Spain
- +20 more
Jan 17, 2022
Cytomegalovirus Infection After HSCT and PT-CY as GVHD
Completed
- CMV Infection
-
Malaga, SpainMaria Jesus Pascual
Mar 30, 2022
Covid19 Trial in Germany (CRP-apheresis)
Recruiting
- Covid19
- CRP-apheresis
-
Essen, NRW, Germany
- +3 more
Mar 29, 2022
Rare Diseases, Genetic Predisposition to Disease Trial in Tübingen (WGS Diagnostic Blood take for genetic diagnostic., Hair
Recruiting
- Rare Diseases
- Genetic Predisposition to Disease
- WGS Diagnostic Blood take for genetic diagnostic.
- Hair collection
-
Tübingen, Germany
- +1 more
May 17, 2022
Triple-Negative Breast Tumors, Breast Tumor, Breast Cancer Trial in Worldwide (Trilaciclib, Gemcitabine, Carboplatin)
Terminated
- Triple-Negative Breast Neoplasms
- +3 more
- Trilaciclib
- +2 more
-
Tucson, Arizona
- +53 more
Feb 24, 2022
Peanut Hypersensitivity, Food Allergy, Food Hypersensitivity Trial in Chapel Hill, Dallas (Liquid Peanut Extract, Placebo
Completed
- Peanut Hypersensitivity
- +3 more
- Liquid Peanut Extract
- Placebo Glycerin SLIT
-
Chapel Hill, North Carolina
- +1 more
Dec 19, 2021
Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL) Trial in Rochester (Acalabrutinib, Rituximab)
Active, not recruiting
- Chronic Lymphocytic Leukemia (CLL)
- Small Lymphocytic Lymphoma (SLL)
-
Rochester, New YorkUniversity of Rochester
Feb 7, 2022
Solid Tumor, Adult, NSCLC, Urothelial Carcinoma Trial (BA3071, Nivolumab)
Not yet recruiting
- Solid Tumor, Adult
- +8 more
- BA3071
- Nivolumab
- (no location specified)
Jan 5, 2022
Follicular Lymphoma Trial in Worldwide (tisagenlecleucel)
Active, not recruiting
- Follicular Lymphoma
- tisagenlecleucel
-
Duarte, California
- +29 more
Nov 2, 2022
Advanced Gastric Adenocarcinoma Trial in Seoul (AZD1775, paclitaxel)
Completed
- Advanced Gastric Adenocarcinoma
-
Seoul, Korea, Republic ofSamsung Medical center
Jun 13, 2022
DLBCL - Diffuse Large B Cell Lymphoma, Follicular Lymphoma Trial in Xiamen (Lenalidomide combined with G-CHOP (LO CHOP))
Recruiting
- DLBCL - Diffuse Large B Cell Lymphoma
- Follicular Lymphoma
- Lenalidomide combined with G-CHOP (LO CHOP)
-
Xiamen, Fujian, ChinaBing Xu
Nov 28, 2023
Cancer Trial in Wuhan (RD133)
Recruiting
- Cancer
-
Wuhan, Hubei, ChinaTongji Hospital of Tongji Medical College, Huazhong University o
Apr 26, 2022
HER2 Positive Advanced Gastric Cancer Trial in Beijing (Samples including blood and tissue collection, CTC detection, ctDNA
Recruiting
- HER2 Positive Advanced Gastric Cancer
- Samples including blood and tissue collection
- +5 more
-
Beijing, Beijing, ChinaBeijing Cancer Hospital
Apr 20, 2022
Head and Neck Squamous Cell Carcinoma Trial (Carrilizumab, bevacizumab,capecitabine)
Not yet recruiting
- Head and Neck Squamous Cell Carcinoma
- Carrilizumab, bevacizumab,capecitabine
- (no location specified)
Jul 20, 2023